ATE275955T1 - Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung - Google Patents
Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutungInfo
- Publication number
- ATE275955T1 ATE275955T1 AT98929466T AT98929466T ATE275955T1 AT E275955 T1 ATE275955 T1 AT E275955T1 AT 98929466 T AT98929466 T AT 98929466T AT 98929466 T AT98929466 T AT 98929466T AT E275955 T1 ATE275955 T1 AT E275955T1
- Authority
- AT
- Austria
- Prior art keywords
- blood flow
- coronary blood
- increase coronary
- phospholamban
- phospholamban inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88226297A | 1997-06-25 | 1997-06-25 | |
| US93711897A | 1997-09-24 | 1997-09-24 | |
| PCT/FI1998/000559 WO1999000132A1 (en) | 1997-06-25 | 1998-06-25 | Use of phospholamban inhibitors for increasing coronary flow |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE275955T1 true ATE275955T1 (de) | 2004-10-15 |
Family
ID=27128657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98929466T ATE275955T1 (de) | 1997-06-25 | 1998-06-25 | Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1001774B1 (de) |
| JP (1) | JP2002506457A (de) |
| AT (1) | ATE275955T1 (de) |
| AU (1) | AU7921698A (de) |
| BR (1) | BR9810335A (de) |
| CA (1) | CA2294550A1 (de) |
| DE (1) | DE69826287T2 (de) |
| ES (1) | ES2227846T3 (de) |
| WO (1) | WO1999000132A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968959A (en) * | 1997-12-12 | 1999-10-19 | Orion Corporation | Method for the prevention and treatment of stunned myocardium |
| GB0611781D0 (en) * | 2006-06-14 | 2006-07-26 | Argenta Discovery Ltd | 2-Oxo-2H-Chromene Compounds |
| WO2021161296A1 (en) | 2020-02-12 | 2021-08-19 | Aquabot Ltd. | Self-closing sack |
-
1998
- 1998-06-25 JP JP50530799A patent/JP2002506457A/ja not_active Ceased
- 1998-06-25 CA CA002294550A patent/CA2294550A1/en not_active Abandoned
- 1998-06-25 BR BR9810335-0A patent/BR9810335A/pt not_active IP Right Cessation
- 1998-06-25 AT AT98929466T patent/ATE275955T1/de not_active IP Right Cessation
- 1998-06-25 WO PCT/FI1998/000559 patent/WO1999000132A1/en active IP Right Grant
- 1998-06-25 AU AU79216/98A patent/AU7921698A/en not_active Abandoned
- 1998-06-25 EP EP98929466A patent/EP1001774B1/de not_active Expired - Lifetime
- 1998-06-25 ES ES98929466T patent/ES2227846T3/es not_active Expired - Lifetime
- 1998-06-25 DE DE69826287T patent/DE69826287T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999000132A1 (en) | 1999-01-07 |
| AU7921698A (en) | 1999-01-19 |
| DE69826287D1 (de) | 2004-10-21 |
| CA2294550A1 (en) | 1999-01-07 |
| DE69826287T2 (de) | 2005-10-27 |
| EP1001774A1 (de) | 2000-05-24 |
| EP1001774B1 (de) | 2004-09-15 |
| BR9810335A (pt) | 2000-09-05 |
| ES2227846T3 (es) | 2005-04-01 |
| JP2002506457A (ja) | 2002-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE356113T1 (de) | Probucolbernsteinsäureester zur hemmung der expression von vcam-1 | |
| ES2128283T1 (es) | Profarmacos de inhibidores de trombina. | |
| DE69516866D1 (de) | Stereochemische wortmanninderivate | |
| DE69826847D1 (de) | Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose | |
| DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
| NO961888D0 (no) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser | |
| ATE127474T1 (de) | Neue peptidasen und isomerasen-inhibitoren. | |
| DK1039895T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrer, estere eller amider til behandling af GLC1A-glaukom | |
| NO942641L (no) | Inhibisjon av fosfatidylinositol 3-kinase med wortmannin og analoger derav | |
| ES8800050A1 (es) | Un procedimiento para la preparacion de derivados de cetona electrofilicos activados de sustratos de peptidasa, utiles en la inhibicion de enzimas proteasas | |
| DK130387A (da) | Transglutaminase inhibitorer | |
| DE69534908D1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| DE69205859D1 (de) | Verwendung von oberflächenaktiven Mitteln zur Verbesserung des Rückflusses von Venenkathetern. | |
| ATE239500T1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
| DE69102936D1 (de) | Bis(alkyl-substituierte-4-hydroxyphenylthio)alkan-Analoga als Inhibitoren der Kataraktentstehung. | |
| FR2599752B1 (fr) | Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine | |
| ATE275955T1 (de) | Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung | |
| CY1107039T1 (el) | Αναστολεις τριπεπτιδυλ πεπτιδασης | |
| ATE212845T1 (de) | Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen | |
| ATE181240T1 (de) | Verwendung von somatostatinanalogen zur behandlung von melanomen | |
| DK431189D0 (da) | Peptidaseinhibitorer | |
| DE69720064D1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| GR1001145B (el) | Μεθοδος για την αντιμετωπιση αγγειακων ασθενειων. | |
| NO20033541L (no) | Anvendelse av fosfodiesteraseinhibitorer av type 4 ved hjertemuskelsykdommer | |
| DE50003730D1 (de) | Caspase 8-inhibitoren zur immunsuppression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |